CBT

CBT Net Receivables

$731.00MQuarterly · USD

Period ending:

CBT FY Net ReceivablesUSD
CBT FY Net Receivables1985-09-30: $254.50M1986-09-30: $210.60M1987-09-30: $254.00M1988-09-30: $296.90M1989-09-30: $281.50M1990-09-30: $285.20M1991-09-30: $237.60M1992-09-30: $265.50M1993-09-30: $258.10M1994-09-30: $272.80M1995-09-30: $292.80M1996-09-30: $363.80M1997-09-30: $288.60M1998-09-30: $284.00M1999-09-30: $321.00M2000-09-30: $280.00M2001-09-30: $267.00M2002-09-30: $304.00M2003-09-30: $333.00M2004-09-30: $384.00M2005-09-30: $430.00M2006-09-30: $534.00M2007-09-30: $563.00M2008-09-30: $646.00M2009-09-30: $452.00M2010-09-30: $575.00M2011-09-30: $659.00M2012-09-30: $696.00M2013-09-30: $848.00M2014-09-30: $688.00M2015-09-30: $477.00M2016-09-30: $456.00M2017-09-30: $527.00M2018-09-30: $637.00M2019-09-30: $530.00M2020-09-30: $418.00M2021-09-30: $645.00M2022-09-30: $836.00M2023-09-30: $695.00M2024-09-30: $733.00M2025-09-30: $671.00M$848.00M$0.00
1985-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CBT net receivables history

Net amount expected from customer receivables. The available annual fiscal periods series contains 41 observations from Sep 30, 1985 to Sep 30, 2025.

Cabot Corp Net Receivables — Annual fiscal periods (USD)
Period endingNet Receivables (USD)
671,000,000
733,000,000
695,000,000
836,000,000
645,000,000
418,000,000
530,000,000
637,000,000
527,000,000
456,000,000
477,000,000
688,000,000
848,000,000
696,000,000
659,000,000
575,000,000
452,000,000
646,000,000
563,000,000
534,000,000
430,000,000
384,000,000
333,000,000
304,000,000
267,000,000
280,000,000
321,000,000
284,000,000
288,600,000
363,800,000
292,800,000
272,800,000
258,100,000
265,500,000
237,600,000
285,200,000
281,500,000
296,900,000
254,000,000
210,600,000
254,500,000

Compare net receivables

All CBT financial metrics · CBT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.